ALK and metastatic malignant neoplasm in the lymph nodes: In this group, the risk of death was not significantly related to age, gender, ALK abnormality testing method (IHC vs. FISH vs. NGS), body weight, smoking status, location of lymph node metastases, size and location of tumor, nor to bone metastases and secondary CNS metastases.